Insulin-Like Growth Factor Binding Proteins Increase Intracellular Calcium Levels in Two Different Cell Lines

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Seurin, Danielle ^a   Lombet, Alain ^b   Babajko, Sylvie ^c   Godeau, François ^a   Ricort, Jean Marc ^d,e  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b Universite Paris Sud   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d Ecole Normale Superieure de Cachan   (France)

^e UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PERTUSSIS TOXIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6;

ARTICLE; CALCIUM CELL LEVEL; CELL LINE; CELL MEMBRANE; CELL STRAIN C2 MYOBLAST; CELL STRAIN MCF 7; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; INTRACELLULAR SIGNALING; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION;

EID: 84875090185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059323     Document Type: Article

References (42)

1. Baserga R, Prisco M, Hongo A (1999) IGFs and cell growth. In: Rosenfeld RG, Roberts CT, Jr., editors. The IGF System. Totowa, NJ: Humana Press. 329-353.
2. Jones JI, Clemmons DR, (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 16: 3-34.
3. LeRoith D, Werner H, Beitner-Johnson D, Roberts CJ, (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143-163.
4. Firth SM, Baxter RC, (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824-854.
5. Holly J, Perks C, (2006) The role of insulin-like growth factor binding proteins. Neuroendocrinology 83: 154-160.
6. Ruan W, Lai M, (2010) Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? Acta Diabetol 47: 5-14.
7. Jogie-Brahim S, Feldman D, Oh Y, (2009) Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev 30: 417-437.
8. Perks CM, Holly JM, (2008) IGF binding proteins (IGFBPs) and regulation of breast cancer biology. J Mammary Gland Biol Neoplasia 13: 455-469.
9. Colomer J, Means AR, (2007) Physiological roles of the Ca2+/CaM-dependent protein kinase cascade in health and disease. Subcell Biochem 45: 169-214.
10. Clapham D, (1995) Calcium signaling. Cell 80: 259-268.
11. Ricort J-M, (2004) Insulin-like growth factor binding protein (IGFBP) signalling. Growth Hormone and IGF Research 14: 277-286.
12. Ricort J-M, Lombet A, Lassarre C, Binoux M, (2002) Insulin-like growth factor binding protein-3 increases intracellular calcium concentrations in MCF-7 breast carcinoma cells. FEBS lett 527: 293-297.
13. Pinset C, Montarras D, Chenevert J, Minty A, Barton P, et al. (1988) Control of myogenesis in the mouse myogenic C2 cell line by medium composition and by insulin: characterization of permissive and inducible C2 myoblasts. Differentiation 38: 28-34.
14. Seurin D, Lassarre C, Bienvenu G, Babajko S, (2003) Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development. Eur J Cancer 38: 2058-2065.
15. Yamada M, Lombet A, Forgez P, Rostene W, (1998) Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in chinese hamster ovary cells. Life Sci 62: 375-380.
16. Hoeflich A, Reisinger R, Lahm H, Kiess W, Blum WF, et al. (2001) Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res 61: 8601-8610.
17. Martin JL, Baxter RC, (2011) Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors 29: 235-244.
18. Iosef C, Vilk G, Gkourasas T, Lee KJ, Chen BP, et al. (2010) Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate. Cell Signal 22: 1033-1043.
19. Qui M, Green S, (1992) PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 9: 705-717.
20. Schutt BS, Langkamp M, Rauschnabel U, Ranke MB, Elmlinger MW, (2004) Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 32: 859-868.
21. Uzoh CC, Holly JM, Biernacka KM, Persad RA, Bahl A, et al. (2011) Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or-independent mechanisms and reduces the efficacy of docetaxel. Br J Cancer 104: 1587-1593.
22. Leal SM, Liu Q, Shian Huang S, San Huang J, (1997) The type V tranforming growth factor ß receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem 272: 20572-20576.
23. Leal SM, Shian Huang S, San Huang J, (1999) Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-ß receptor in mink lung epithelial cells. J Biol Chem 274: 6711-6717.
24. Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, et al. (2003) Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1. FASEB J 17: 2068-2081.
25. Zhu W, Shiojima I, Ito Y, Li Z, Ikeda H, et al. (2008) IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 454: 345-349.
26. Berfield AK, Andress DL, Abrass CK, (2000) IGFBP-5(201-218) stimulates Cdc42GAP aggregation and filopodia formation in migrating mesangial cells. Kidney Int 57: 1991-2003.
27. Jones JI, Gockerman A, Busby WH, Wright G, Clemmons DR, (1993) Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5ß1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90: 10553-10557.
28. Morgan MR, Byron A, Humphries MJ, Bass MD, (2009) Giving off mixed signals-distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour. IUBMB Life 61: 731-738.
29. Jones JI, Doerr ME, Clemmons DR, (1995) Cell migration: interactions among integrins, IGFs and IGFBPs. Prog Growth Factor Res 6: 319-327.
30. Chesik D, De KJ, Bron R, Fuhler GM, (2010) Insulin-like growth factor binding protein-1 activates integrin-mediated intracellular signaling and migration in oligodendrocytes. J Neurochem 113: 1319-1330.
31. Mitra SK, Hanson DA, Schlaepfer DD, (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68.
32. Giannone G, Ronde P, Gaire M, Beaudouin J, Haiech J, et al. (2004) Calcium rises locally trigger focal adhesion disassembly and enhance residency of focal adhesion kinase at focal adhesions. J Biol Chem 279: 28715-28723.
33. Oh Y, Müller HL, Lamson G, Rosenfeld RG, (1993) Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268: 14964-14971.
34. Ricort J-M, Binoux M, (2001) Insulin-like growth factor binding protein-3 inhibits type 1 insulin-like growth factor receptor activation independently of its insulin-like growth factor binding affinity. Endocrinology 142: 108-113.
35. Flynn RS, Mahavadi S, Murthy KS, Kellum JM, Kuemmerle JF, (2009) Insulin-like growth factor-binding protein-5 stimulates growth of human intestinal muscle cells by activation of G{alpha}i3. Am J Physiol Gastrointest Liver Physiol 297: G1232-G1238.
36. Drop SL, Schuller AG, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, et al. (1992) Structural aspects of the IGFBP family. Growth Regul 2: 69-79.
37. Hwa V, Oh Y, Rosenfeld R, (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20: 761-787.
38. Baxter RC, (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278: E967-E976.
39. Clemmons DR, (2001) Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr Rev 22: 800-817.
40. Brubaker PL, Drucker DJ, (2002) Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Receptors Channels 8: 179-188.
41. Schneider MR, Wolf E, Hoeflich A, Lahm H, (2002) IGF-binding protein-5: flexible player in the IGF system and effector on its own. J Endocrinol 172: 423-440.
42. Wheatcroft SB, Kearney MT, (2009) IGF-dependent and IGF-independent actions of IGF-binding protein-1 and-2: implications for metabolic homeostasis. Trends Endocrinol Metab 20: 153-162.